Clinical trials in metastatic prostate cancer--has there been real progress in the past decade?
about
Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancerIntegrin involvement in freeze resistance of androgen-insensitive prostate cancer.A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells.The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer.CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling.KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis.Survivin is a potential mediator of prostate cancer metastasis.Vitamin D(3) cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial-mediated apoptosis and necrosis.The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications.Chemotherapy for older patients with prostate cancer.Evolving treatment paradigms for locally advanced and metastatic prostate cancer.Alcohol consumption pattern and risk of Barrett's oesophagus and erosive oesophagitis: an Italian case-control study.Peperotetraphin inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and apoptosis.Cryoablative response of prostate cancer cells is influenced by androgen receptor expression.Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer.Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancerMolecular Approaches To Target GPCRs in Cancer Therapy.
P2860
Q28659468-2F4C5F6A-5B2F-4E5E-A63A-30D51E0CAC45Q33848813-A2DF381B-709B-4A5B-9702-81A490DBC8C3Q33905704-D9015604-6CE3-4351-A82C-9AC3947CD0BEQ33976977-2E72374F-3AE9-482A-9221-915C04D4257BQ34786431-54E814A3-F31F-461B-BA12-94FFE9C9B407Q34791651-01EAEE45-B166-44A4-9D72-D089C6783C49Q35142549-2B5655A9-90EC-4E5C-BA38-38379FA0F916Q35605962-84AEDBF9-7517-4BB8-BCB7-B798F16CF1DBQ36352082-DF0BEE8F-188B-4DBD-9088-8892264274A0Q36596741-37995F82-64B9-45C9-A4DD-7E079AA7DA2DQ36668260-3415DA12-3215-4FB9-859A-5376A68DD1A2Q38800032-E8686F86-7EA6-431E-873F-9D9275E4119FQ38921011-5BF92606-2E6E-4DE8-B7F6-F0BC8902E098Q40015151-A3F8EE58-BD3A-41E3-B7F3-ED9BCFE004B9Q40302198-C740F329-11F0-426C-B890-6F4CAF2DB619Q41983632-2869F932-02D6-4936-8074-7B0216E177D2Q46850333-C83788EE-699D-463F-AA26-9E9EC4816A8D
P2860
Clinical trials in metastatic prostate cancer--has there been real progress in the past decade?
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Clinical trials in metastatic ...... l progress in the past decade?
@ast
Clinical trials in metastatic ...... l progress in the past decade?
@en
type
label
Clinical trials in metastatic ...... l progress in the past decade?
@ast
Clinical trials in metastatic ...... l progress in the past decade?
@en
prefLabel
Clinical trials in metastatic ...... l progress in the past decade?
@ast
Clinical trials in metastatic ...... l progress in the past decade?
@en
P2093
P1476
Clinical trials in metastatic ...... l progress in the past decade?
@en
P2093
Daniel P Petrylak
Maha Hussain
Manish S Bhandari
P304
P356
10.1016/J.EJCA.2005.02.008
P577
2005-04-01T00:00:00Z